Results 1 to 10 of about 8,288 (169)

Seroprevalence of IgG antibodies against diphtheria antitoxin among migrant workers in Singapore, 2016–2019 [PDF]

open access: yesBMC Public Health, 2022
Background Since the last local case of diphtheria in 1992, there had not been any case in Singapore until an autochthonous case was reported in 2017.
Li Wei Ang   +10 more
doaj   +2 more sources

Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin [PDF]

open access: yesEmerging Infectious Diseases, 2016
Diphtheria antitoxin for therapeutic use is in limited supply. A potential source might be affinity-purified antibodies originally derived from plasma of adults who received a booster dose of a vaccine containing diphtheria toxoid. These antibodies might
Jesús F. Bermejo-Martin   +5 more
doaj   +2 more sources

A complex case of diphtheria in a pediatric patient: complications of renal failure and myocarditis [PDF]

open access: yesInternational Journal of Emergency Medicine
Background Diphtheria remains a life-threatening infectious disease in low- and middle-income countries, particularly where immunization coverage is incomplete.
Abdullahi Ahmed Ahmed   +4 more
doaj   +2 more sources

Clinical features, prognosis, and treatment outcomes of diphtheria in children: a retrospective cohort study at children’s hospital, Sukkur [PDF]

open access: yesBMC Infectious Diseases
Background Diphtheria remains a major pediatric health threat in under-resourced settings, particularly in populations with low immunization coverage. Despite being vaccine-preventable, outbreaks continue to occur in Pakistan due to delayed recognition ...
Waqar Ahmed   +8 more
doaj   +2 more sources

Diphtheria outbreak in Somalia: a weekly sitrep on the recent health crisis-2025 [PDF]

open access: yesTropical Medicine and Health
The global diphtheria incidence has fallen following widespread use of the diphtheria–tetanus–pertussis (DTP) vaccine; pockets of low coverage and disrupted health services continue to fuel outbreaks.
Saadaq Adan Hussein   +14 more
doaj   +2 more sources

Clinical presentation and predictors of hospital mortality of diphtheria in Nigeria, July 2023 to April 2024: a single-center study [PDF]

open access: yesBMC Infectious Diseases
Background Despite recurrent outbreaks of diphtheria in Nigeria, there is a lack of in-depth analysis of hospitalization outcomes. Herein, we describe the sociodemographic, clinical, and laboratory features associated with hospitalization outcomes ...
Abdurrazzaq Alege   +7 more
doaj   +2 more sources

A population-level analysis of armed conflict and diphtheria at the subnational level in the WHO African Region 2017–2024 [PDF]

open access: yesBMC Global and Public Health
Background Diphtheria has been re-emerging around the world at alarming rates, raising concerns about emergency preparedness, especially when global supplies of life-saving diphtheria antitoxin are insufficient.
Tierney O’Sullivan, Lindsay T. Keegan
doaj   +2 more sources

Passive Immunisation in the Treatment of Infectious Diseases Related to Highly Potent Bacterial Toxins [PDF]

open access: yesBiomedicines
The discovery of microbial toxins as the primary factors responsible for disease manifestations and the discovery that these toxins could be neutralised by antitoxins are linked to the birth of immunology. In the late 19th century, the serum or plasma of
Marta Prygiel   +3 more
doaj   +2 more sources

Rare manifestations of cutaneous diphtheria: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background This case report presents an exceptionally rare and atypical presentation of diphtheria in a 17-year-old female of Hausa ethnicity residing in an area with an elevated incidence within Kano State, Nigeria.
Salma Ali Suwaid   +5 more
doaj   +2 more sources

Antimicrobial Susceptibility of Toxin-Producing Corynebacterium diphtheriae and C. ulcerans in Belgium [PDF]

open access: yesAntibiotics
Background/Objectives: Despite a significant reduction in diphtheria incidence and mortality due to vaccination, antitoxin therapy and antibiotic treatments, a concerning resurgence is occurring in Europe.
Zan Janssen   +6 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy